Diabetes drug shows promise in Alzheimer's Disease | wzzm13.com: Kalamazoo (WZZM) - Researchers at Metabolic Solutions in Kalamazoo announced the results of a phase two clinical trial.
The drug being studied was originally developed to treat diabetes, but showed potential as a treatment for Alzheimer's disease.
The study looked at the decline in brain glucose metabolism and its link to Alzheimer's.
The drug maintained metabolism levels in key regions of the brain affected by mental decline.
No comments:
Post a Comment